During the past decade, Medicines Evaluation Unit conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 14 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 13 clinical trials were completed. i.e. 68.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medicines Evaluation Unit" #1 sponsor was "Chiesi Farmaceutici S.p.A." with 13 trials, followed by "Boehringer Ingelheim" with 7 trials sponsored, "Verona Pharma plc" with 4 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medicines Evaluation Unit" #1 collaborator was "Ario Pharma Ltd" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Chiesi UK" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Medicines Evaluation Unit" are "Asthma" (18 trials), "Chronic Obstructive Pulmonary Disease" (10 trials), "COPD" (7 trials), "Cystic Fibrosis" (7 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (6 trials). Many other conditions were trialed in "Medicines Evaluation Unit" in a lesser frequency.

Most popular intervention types in "Medicines Evaluation Unit" are "Drug" (72 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Glycopyrrolate" (3 trials), "BI 443651" (2 trials), "EP395" (2 trials) and "IVA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medicines Evaluation Unit" are 73 trials for "All" genders.

Currently, there are NaN active trials in "Medicines Evaluation Unit". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Medicines Evaluation Unit, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medicines Evaluation Unit, 37 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".